$54.4 Billion in Deals and Counting: Analyzing Three Quarters of Cell and Gene Therapy Funding
Over 54 BN across funding mechanisms. Private, VC, SPAC and and IPO Over 20Billion The enormous amount of funding presages confidence in discoveries of future marketable products as well as platforms in cell and gene therapy. With an aggressive third quarter 2021 for funding, it is worthwhile to total and assess where we are. In […]